Scarica l'app Stockscreener
62.67
0.63%
0.39
Dopo l'orario di chiusura:
62.87
0.20
+0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTCT Giù?
Forum
Previsione
Ptc Therapeutics Inc Borsa (PTCT) Ultime notizie
37 new hires get options to buy PTC shares at $65.96 - stocktitan.net
PTC Therapeutics, Inc. (PTCT) Stock Forecasts - Yahoo! Finance Canada
PTC Therapeutics stock gets a Fabry therapy catalyst - ad-hoc-news.de
PTC Therapeutics stock rises as third quarter data strengthen outlook - ad-hoc-news.de
(PTCT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
PTC Therapeutics, Inc. (PTCT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cantor raises PTC Therapeutics stock price target on Fabry deal By Investing.com - Investing.com Canada
Cantor Fitzgerald Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $137.00 - MarketBeat
Cantor Fitzgerald maintains Overweight rating on PTC Therapeutics, $137 price target - TradingView
PTC Therapeutics completes ST-920 gene therapy acquisition By Investing.com - Investing.com Nigeria
PTC Therapeutics completes ST-920 gene therapy acquisition - Investing.com
PTC Therapeutics Closes Acquisition of the ST-920 Gene Therapy for Fabry Disease - Yahoo Finance
PTC Completes Acquisition of ST-920, BLA Submission Expected in Q4 2026 - TradingView
A one-time gene therapy for Fabry disease is now PTC’s. FDA filing expected later in 2026. - Stock Titan
PTC Therapeutics (PTCT) Could Be 36% Undervalued Following Pipeline Progress - Yahoo Finance
Bank of America Corp DE Takes $118.46 Million Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics director Schmertzler sells $1.35m shares - Investing.com
Wall Street Zen Upgrades PTC Therapeutics (NASDAQ:PTCT) to "Strong-Buy" - MarketBeat
PTC Therapeutics director Schmertzler sells $1.35m shares By Investing.com - Investing.com Nigeria
PTC Therapeutics (NASDAQ:PTCT) Director Sells 10,000 Shares - MarketBeat
PTC Therapeutics Director Michael Schmertzler Executes 20,000 Share Sale Under 10b5-1 Trading Plan - Kalkine Media
PTC Therapeutics (NASDAQ: PTCT) director offloads 20,000 shares under trading plan - stocktitan.net
Is PTC Therapeutics (PTCT) Undervalued After Its Recent Pullback? - simplywall.st
ETFs Investing in PTC Therapeutics, Inc. Stocks - TradingView
PTC Therapeutics at Morgan Stanley conference: sephience drives outlook By Investing.com - Investing.com Nigeria
PTC Therapeutics, Inc. $PTCT Shares Sold by Engineers Gate Manager LP - MarketBeat
California State Teachers Retirement System Lowers Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Leerink Partners Begins Coverage on PTC Therapeutics (NASDAQ:PTCT) - MarketBeat
(PTCT) Volatility Zones as Tactical Triggers - Stock Traders Daily
PTC Therapeutics director Schmertzler sells $1.35m in stock - investing.com
PTC Therapeutics director Schmertzler sells $1.35m in stock By Investing.com - Investing.com India
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Director Sells 10,000 Shares of Stock - MarketBeat
Director stock sale at PTC Therapeutics (PTCT) ran on a preset 10b5-1 plan - Stock Titan
PTC Therapeutics at cantor healthcare conference: sephience drives growth By Investing.com - Investing.com Canada
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $2.32 Million in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics at Wells Fargo conference: sufiance drives growth plan By Investing.com - Investing.com Canada
Hsbc Holdings PLC Reduces Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
Corient Private Wealth LP Makes New Investment in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last? - Eastern Progress
Wells Fargo Sticks to Its Buy Rating for PTC Therapeutics (PTCT) - theglobeandmail.com
Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $109 - Moomoo
Moore Capital Management LP Acquires 30,894 Shares of PTC Therapeutics, Inc. $PTCT - MarketBeat
Wellington Management Group LLP Raises Stake in PTC Therapeutics, Inc. $PTCT - MarketBeat
Empowered Funds LLC Acquires Shares of 81,271 PTC Therapeutics, Inc. $PTCT - MarketBeat
Legal & General Group Plc Makes New Investment in PTC Therapeutics, Inc. $PTCT - MarketBeat
Palo Alto Investors LP Invests $74.95 Million in PTC Therapeutics, Inc. $PTCT - MarketBeat
Hsbc Holdings PLC Takes $10.76 Million Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics, Inc.: Upfront Payment of $111 Million, Plus Up to an Additional $100 Million in Contingent Milestone Payments >PTCT - Moomoo
PTC Therapeutics director Michael Schmertzler sells $1.8m in shares - Investing.com
Michael Schmertzler Sells 12,500 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
Jefferies Financial Group Inc. Purchases Shares of 1,357,042 PTC Therapeutics, Inc. $PTCT - MarketBeat
Broader Sephience PKU Data Could Be A Game Changer For PTC Therapeutics (PTCT) - Sahm
PTC Therapeutics to Participate in Upcoming Investor Conferences - Sahm
PTC Therapeutics (PTCT) director sells 25K shares under trading plan - stocktitan.net
PTC Therapeutics executives will speak at three September healthcare conferences - Stock Titan
The Manufacturers Life Insurance Company Takes $36.05 Million Position in PTC Therapeutics, Inc. $PTCT - marketbeat.com
Jupiter Topco LLC Makes New Investment in PTC Therapeutics, Inc. $PTCT - MarketBeat
Ieq Capital LLC Acquires Shares of 19,611 PTC Therapeutics, Inc. $PTCT - MarketBeat
435,691 Shares in PTC Therapeutics, Inc. $PTCT Purchased by Parkman Healthcare Partners LLC - MarketBeat
PTC Therapeutics (NASDAQ: PTCT) affiliate to sell 50,000 shares - stocktitan.net
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):